BioSpace News Archive

Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced financial results and recent corporate highlights for the first quarter ended March 31, 2021.

China Pharma Holdings, Inc.China Pharma Holdings, Inc., a specialty pharmaceutical company, announced financial results for the quarter ended March 31, 2021.

Veracyte, Inc. (Nasdaq: VCYT) announced that data reinforcing the diagnostic performance and utility of the Envisia® Genomic Classifier are being shared at the American Thoracic Society (ATS) 2021 International Conference, taking place today through May 18.

Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its first quarter 2021 (“Q1 2021) operational and financial results

Echolight Medical, is introducing REMS diagnostic technology at the Florida Orthopedic Society Annual Scientific Meeting in Tampa, Florida, May 14-15, 2021.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI™ (pegcetacoplan), the first and only targeted C3 therapy for treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH).

MicroGen Diagnostics , the industry leader in providing next generation DNA sequencing (NGS) for clinical diagnostics, has been selected for a study evaluating the impact of space travel on the human urinary microbiome.

restor3d is pleased to announce an exciting merger with Kinos Medical, a leading total ankle replacement company.

The Southern California Biomedical Council (SoCalBio) -- the trade association for the bioscience and digital health industries in Greater Los Angeles -- today announced its selection of Palos Verdes Peninsula High School graduating senior, Jason Apostol, as winner of the 2021 Southern California BioGENEius Challenge